Cargando…

Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations

PURPOSE: Epidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonelli, Patrizia, Tuccillo, Franca M, Federico, Antonella, Napolitano, Maria, Borrelli, Antonella, Melisi, Daniela, Rimoli, Maria G, Palaia, Raffaele, Arra, Claudio, Carinci, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497877/
https://www.ncbi.nlm.nih.gov/pubmed/23180963
http://dx.doi.org/10.2147/IJN.S34723
_version_ 1782249769904635904
author Bonelli, Patrizia
Tuccillo, Franca M
Federico, Antonella
Napolitano, Maria
Borrelli, Antonella
Melisi, Daniela
Rimoli, Maria G
Palaia, Raffaele
Arra, Claudio
Carinci, Francesco
author_facet Bonelli, Patrizia
Tuccillo, Franca M
Federico, Antonella
Napolitano, Maria
Borrelli, Antonella
Melisi, Daniela
Rimoli, Maria G
Palaia, Raffaele
Arra, Claudio
Carinci, Francesco
author_sort Bonelli, Patrizia
collection PubMed
description PURPOSE: Epidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer cell line MKN-45. However, high doses of ibuprofen were required to elicit these antiproliferative effects in vitro. The present research compared the antiproliferative effects of ibuprofen delivered freely and released by poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) in MKN-45 cells. METHODS: MKN-45 human gastric adenocarcinoma cells were treated with ibuprofen-loaded PLGA NPs. The proliferation of MKN-45 cells was then assessed by cell counting. The uptake of NPs was imaged by fluorescence microscopy and flow cytometry. The release of ibuprofen from ibuprofen-loaded PLGA NPs in the cells was evaluated by gas chromatography–mass spectrometry. RESULTS: Dramatic inhibition of cellular proliferation was observed in cells treated with ibuprofen-loaded PLGA NPs versus those treated with free ibuprofen at the same concentration. The localization of NPs was cytoplasmic. The initiation of ibuprofen release was rapid, commencing within 2 hours, and then increased slowly over time, reaching a maximum concentration at 24 hours. The inhibition of proliferation was confirmed to be due to the intracellular release of ibuprofen from the NPs. Using PLGA NPs as carriers, ibuprofen exerted an antiproliferative activity at concentrations > 100 times less than free ibuprofen, suggesting greater efficiency and less cellular toxicity. In addition, when carried by PLGA NPs, ibuprofen more quickly induced the expression of transcripts involved in proliferation and invasiveness processes. CONCLUSION: Ibuprofen exerted an antiproliferative effect on MKN-45 cells at low concentrations. This effect was achieved using PLGA NPs as carriers of low doses of ibuprofen.
format Online
Article
Text
id pubmed-3497877
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-34978772012-11-23 Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations Bonelli, Patrizia Tuccillo, Franca M Federico, Antonella Napolitano, Maria Borrelli, Antonella Melisi, Daniela Rimoli, Maria G Palaia, Raffaele Arra, Claudio Carinci, Francesco Int J Nanomedicine Original Research PURPOSE: Epidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer cell line MKN-45. However, high doses of ibuprofen were required to elicit these antiproliferative effects in vitro. The present research compared the antiproliferative effects of ibuprofen delivered freely and released by poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) in MKN-45 cells. METHODS: MKN-45 human gastric adenocarcinoma cells were treated with ibuprofen-loaded PLGA NPs. The proliferation of MKN-45 cells was then assessed by cell counting. The uptake of NPs was imaged by fluorescence microscopy and flow cytometry. The release of ibuprofen from ibuprofen-loaded PLGA NPs in the cells was evaluated by gas chromatography–mass spectrometry. RESULTS: Dramatic inhibition of cellular proliferation was observed in cells treated with ibuprofen-loaded PLGA NPs versus those treated with free ibuprofen at the same concentration. The localization of NPs was cytoplasmic. The initiation of ibuprofen release was rapid, commencing within 2 hours, and then increased slowly over time, reaching a maximum concentration at 24 hours. The inhibition of proliferation was confirmed to be due to the intracellular release of ibuprofen from the NPs. Using PLGA NPs as carriers, ibuprofen exerted an antiproliferative activity at concentrations > 100 times less than free ibuprofen, suggesting greater efficiency and less cellular toxicity. In addition, when carried by PLGA NPs, ibuprofen more quickly induced the expression of transcripts involved in proliferation and invasiveness processes. CONCLUSION: Ibuprofen exerted an antiproliferative effect on MKN-45 cells at low concentrations. This effect was achieved using PLGA NPs as carriers of low doses of ibuprofen. Dove Medical Press 2012 2012-11-09 /pmc/articles/PMC3497877/ /pubmed/23180963 http://dx.doi.org/10.2147/IJN.S34723 Text en © 2012 Bonelli et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Bonelli, Patrizia
Tuccillo, Franca M
Federico, Antonella
Napolitano, Maria
Borrelli, Antonella
Melisi, Daniela
Rimoli, Maria G
Palaia, Raffaele
Arra, Claudio
Carinci, Francesco
Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
title Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
title_full Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
title_fullStr Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
title_full_unstemmed Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
title_short Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
title_sort ibuprofen delivered by poly(lactic-co-glycolic acid) (plga) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497877/
https://www.ncbi.nlm.nih.gov/pubmed/23180963
http://dx.doi.org/10.2147/IJN.S34723
work_keys_str_mv AT bonellipatrizia ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT tuccillofrancam ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT federicoantonella ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT napolitanomaria ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT borrelliantonella ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT melisidaniela ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT rimolimariag ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT palaiaraffaele ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT arraclaudio ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations
AT carincifrancesco ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations